Company: FTII
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001641172-25-025250
Chunk: 49

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 8
Chunk 49
---
 contemplated by the Merger Agreement,
(iv) to not redeem any shares of the Company’s Common Stock held by it that may be redeemed, and (v) to waive any adjustment to
the conversion ratio set forth in the Company’s amended and restated certificate of incorporation (as amended from time to time,
the “Charter”) with respect to shares of the Class B Common Stock of the Company held by the Sponsor, in each case, on the
terms and subject to the conditions set forth in the Sponsor Support Agreement.

On
September 20, 2024, the Company filed a Form 8-K with the SEC to report the Merger Agreement and other legal agreements relating to the
Longevity Business Combination, and on February 14, 2025, the Company filed with the SEC an initial Form S-4 (Registration/Proxy Statement)
regarding the Longevity Business Combination (collectively, the “Longevity Disclosure Statements”). Unless specifically stated,
this Quarterly Report on Form 10-Q does not give effect to the proposed Transactions and does not contain the risks associated with the
proposed transactions. For such information, please see Longevity Disclosure Statements. The Company’s S-4 can be accessed on the
EDGAR section of the SEC’s website at www.sec.gov.

PIPE
Subscription Agreement

On
December 13, 2024, the Company entered into a Subscription Agreement (the “Subscription Agreement”) with Yuantian Zhang (the
“Investor”), pursuant to which, among other things, the Investor agreed to subscribe for and purchase, and the Company agreed
to issue and sell to the Investor, 1,000,000 shares of the Company’s Class A Common Stock at a purchase price equal to $5.00 per
share (the “Private Placement”) in connection with a financing effort related to the Merger Agreement. The effectiveness
of the Subscription Agreement is conditioned upon entering into an escrow agreement between the Company and the Investor. In addition,
the closing of the Private Placement is contingent upon the concurrent consummation of the Business Combination with Longevity.

6

On
January 31, 2025, in connection with the Subscription Agreement, the Company and the Investor signed an escrow agreement dated January
23, 2025 (the “Escrow Agreement”), pursuant to which the Company agreed to issue additional 2,000,000 shares of Class A Common
Stock (the “Escrow Shares”, together with any dividends, distributions or other income on the